Bausch + Lomb Corporation announced the appointment of Eduardo C. Alfonso, MD, and Steven H. Collis to its board of directors.
The appointments are effective Jan. 1, 2026, and will bring the total number of directors to 10.
The company aims to leverage the expertise of these new appointees to drive its strategic growth and capitalize on emerging opportunities.
Appointment of Eduardo C. Alfonso, MD
Eduardo C. Alfonso is a renowned ophthalmologist and expert in corneal diseases, bringing valuable clinical insights to the board.
Appointment of Steven H. Collis
Steven H. Collis has a strong background in pharmaceutical distribution, having led Cencora, Inc., through significant revenue growth and global expansion.
Board Expansion
The board of Bausch + Lomb will now consist of 10 directors, aiming to enhance governance and decision-making processes.
- The addition of Eduardo C. Alfonso and Steven H. Collis to the board signifies Bausch + Lomb's focus on strengthening its leadership team.
- With the diverse expertise of the new directors, the company is poised to navigate challenges and seize growth opportunities in the eye health industry.
Bausch + Lomb's strategic appointments reflect a commitment to driving innovation and excellence in eye health, positioning the company for sustainable growth in the global market.